RSLS RSI Chart
Last 7 days
5.9%
Last 30 days
12.5%
Last 90 days
5.9%
Trailing 12 Months
-92.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 8.3M | 0 | 0 | 0 |
2023 | 11.1M | 10.4M | 9.8M | 8.7M |
2022 | 12.8M | 12.2M | 11.3M | 11.2M |
2021 | 12.7M | 14.6M | 14.7M | 13.6M |
2020 | 2.3M | 3.6M | 6.9M | 10.3M |
2019 | 9.5M | 7.2M | 4.5M | 3.3M |
2018 | 9.7M | 10.5M | 10.7M | 9.1M |
2017 | 3.8M | 5.0M | 7.0M | 9.9M |
2016 | 4.2M | 3.9M | 3.6M | 3.4M |
2015 | 3.7M | 3.8M | 3.9M | 4.0M |
2014 | 0 | 0 | 0 | 3.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Oct 25, 2023 | stankovich thomas | sold | -35.37 | 0.27 | -131 | chief financial officer |
Oct 11, 2023 | stankovich thomas | sold | -36.27 | 0.93 | -39.00 | chief financial officer |
Sep 01, 2023 | stankovich thomas | sold | -105 | 0.89 | -118 | chief financial officer |
Aug 24, 2023 | stankovich thomas | sold | -55.38 | 1.42 | -39.00 | chief financial officer |
Aug 04, 2023 | stankovich thomas | sold | -154 | 1.43 | -108 | chief financial officer |
Jul 06, 2023 | stankovich thomas | sold | -155 | 1.47 | -106 | chief financial officer |
Jun 30, 2023 | stankovich thomas | bought | 26,907 | 1.52 | 17,702 | chief financial officer |
May 31, 2023 | stankovich thomas | sold | -236 | 2.41 | -98.00 | chief financial officer |
Apr 30, 2023 | stankovich thomas | sold | -226 | 2.36 | -96.00 | chief financial officer |
Mar 31, 2023 | stankovich thomas | sold | -283 | 2.6 | -109 | chief financial officer |
Which funds bought or sold RSLS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | new | - | 4,228 | 4,228 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | -850 | 2,400 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 190 | 4,854 | 9,121 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | reduced | -83.04 | -16,508 | 2,364 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 40.64 | 204 | 5,492 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | new | - | 4,248 | 4,248 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | sold off | -100 | -18,195 | - | -% |
May 14, 2024 | Qube Research & Technologies Ltd | reduced | -20.00 | -51.00 | 74.00 | -% |
May 13, 2024 | FMR LLC | sold off | - | - | - | -% |
May 13, 2024 | XTX Topco Ltd | new | - | 2,267 | 2,267 | -% |
Unveiling ReShape Lifesciences Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to ReShape Lifesciences Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
ReShape Lifesciences Inc. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -1.9% | 1,944,000 | 1,982,000 | 2,155,000 | 2,254,000 | 2,287,000 | 3,110,000 | 2,798,000 | 2,892,000 | 2,440,000 | 3,142,000 | 3,708,000 | 3,529,000 | 3,221,000 | 4,211,000 | 3,602,000 | 1,702,000 | 780,000 | 787,000 | 333,000 | 386,000 | 1,775,000 |
Gross Profit | -36.8% | 1,165,000 | 1,842,000 | 1,288,000 | 1,194,000 | 1,224,000 | 1,600,000 | 2,101,000 | 1,883,000 | 1,218,000 | 1,776,000 | 2,135,000 | 2,153,000 | 2,284,000 | 2,273,000 | 2,281,000 | 837,000 | 239,000 | 160,000 | -79,000 | -293,000 | 543,000 |
Operating Expenses | -9.7% | 3,375,000 | 3,737,500 | 5,168,000 | 5,170,000 | 6,855,000 | 18,293,000 | 14,402,000 | 11,127,000 | 9,331,000 | 39,292,500 | 16,554,000 | 5,842,000 | 4,541,000 | 5,063,000 | 4,453,000 | 3,835,000 | 5,150,000 | 5,135,000 | 3,663,000 | 6,120,000 | 8,643,000 |
S&GA Expenses | -27.1% | 1,019,000 | 1,398,000 | 1,791,000 | 2,177,000 | 2,182,000 | 2,157,500 | 2,605,000 | 4,636,000 | 4,694,000 | 1,527,500 | 3,246,000 | 4,298,000 | 1,250,000 | 29,000 | 1,160,000 | 831,000 | 3,893,000 | 3,643,000 | 2,489,000 | 4,332,000 | 6,204,000 |
R&D Expenses | -34.5% | 484,000 | 739,000 | 542,000 | 581,000 | 453,000 | 462,000 | 583,000 | 747,000 | 745,000 | 270,000 | 1,425,000 | 103,000 | 571,000 | 898,000 | 859,000 | 465,000 | 1,257,000 | 1,492,000 | 1,174,000 | 1,788,000 | 2,439,000 |
EBITDA Margin | 0.2% | -1.29 | -1.29 | -2.62 | -3.32 | -3.66 | -4.09 | -5.94 | -5.87 | -5.15 | -4.62 | -1.47 | -1.48 | -1.71 | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 296,000 | - | - | - | - | - | 19,000 | 137,000 | 358,000 | 205,000 |
Income Taxes | -54.8% | 14,000 | 31,000 | 3,000 | 4,000 | 14,000 | -49,500 | -400,000 | 9,000 | 30,000 | -297,000 | -30,000 | 28,000 | 25,000 | -82,500 | -39,000 | -50,000 | - | - | - | - | - |
Earnings Before Taxes | -30.7% | -2,179,000 | -1,667,000 | -3,531,000 | -3,489,000 | -2,648,000 | -16,525,000 | -12,549,000 | -9,435,000 | -8,085,000 | -37,546,000 | -17,164,000 | -3,861,000 | -4,849,000 | - | -5,218,000 | -3,654,000 | - | - | - | - | - |
EBT Margin | 0.2% | -1.30 | -1.31 | -2.67 | -3.37 | -3.71 | -4.15 | -6.00 | -5.93 | -5.20 | -4.66 | -1.49 | -1.50 | -1.71 | - | - | - | - | - | - | - | - |
Net Income | -29.2% | -2,193,000 | -1,698,000 | -3,534,000 | -3,493,000 | -2,662,000 | -16,469,000 | -12,186,000 | -9,444,000 | -8,115,000 | -37,249,000 | -17,134,000 | -3,889,000 | -4,874,000 | -8,061,000 | -5,179,000 | -3,604,000 | -5,261,000 | -4,913,000 | -3,706,000 | -6,767,000 | -8,290,000 |
Net Income Margin | 0.2% | -1.31 | -1.31 | -2.67 | -3.33 | -3.68 | -4.11 | -5.94 | -5.91 | -5.18 | -4.64 | -2.31 | -1.51 | -1.71 | - | - | - | - | - | - | - | - |
Free Cashflow | 15.7% | -2,072,000 | -2,457,000 | -2,780,000 | -6,662,000 | -5,061,000 | -2,829,000 | -5,273,000 | -6,422,000 | -7,378,000 | -3,426,000 | -7,800,000 | -2,188,000 | -1,961,000 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -22.8% | 8,231 | 10,663 | 7,827 | 11,852 | 16,352 | 11,142 | 26,485 | 40,357 | 45,623 | 52,531 | 90,790 | 120,013 | 17,343 | 37,061 | 11,962 | 13,873 | 19,229 | 20,393 | 24,657 | 19,199 | 32,368 |
Current Assets | -23.3% | 7,895 | 10,296 | 7,399 | 10,544 | 15,231 | 9,911 | 13,257 | 19,171 | 23,311 | 29,938 | 37,273 | 65,303 | 12,794 | 8,944 | 9,031 | 10,775 | 15,570 | 18,235 | 22,349 | 17,021 | 29,912 |
Cash Equivalents | -44.4% | 2,479 | 4,459 | 1,449 | 4,567 | 8,983 | 3,855 | 6,245 | 11,544 | 15,460 | 22,815 | 29,293 | 40,213 | 1,946 | 3,007 | 1,907 | 1,576 | 8,915 | 2,985 | 19,380 | 13,513 | 24,684 |
Inventory | -7.3% | 3,467 | 3,741 | 3,204 | 3,268 | 3,493 | 3,611 | 4,171 | 4,226 | 3,998 | 3,003 | 3,206 | 2,894 | - | 2,244 | - | - | 1,408 | 1,936 | 2,048 | 2,107 | 1,860 |
Net PPE | -10.0% | 54.00 | 60.00 | 70.00 | 659 | 672 | 698 | 896 | 887 | 1,371 | 1,454 | 1,602 | 1,588 | 891 | 584 | 982 | 1,055 | 2,159 | 1,081 | 1,117 | 1,038 | 1,222 |
Goodwill | - | - | - | - | - | - | - | - | - | - | 1,900 | 22,950 | 23,520 | - | - | - | - | - | - | - | - | - |
Liabilities | -7.6% | 3,697 | 4,000 | 4,744 | 5,114 | 8,594 | 7,481 | 7,532 | 9,581 | 8,664 | 8,197 | 11,478 | 61,881 | 7,245 | 22,573 | 6,040 | 6,695 | 8,157 | 4,544 | 4,592 | 10,812 | 25,850 |
Current Liabilities | -6.8% | 3,519 | 3,777 | 4,469 | 4,404 | 7,602 | 7,481 | 7,532 | 9,209 | 8,170 | 7,530 | 10,336 | 60,496 | 6,863 | 11,605 | 5,050 | 5,599 | 7,188 | 3,977 | 3,905 | 10,090 | 25,031 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 430 | 430 | 430 | - | - | - | - | - |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,000 | 19,952 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 430 | 430 | 430 | - | - | - | - | - |
Shareholder's Equity | -32.0% | 4,534 | 6,663 | 3,083 | 6,738 | 7,758 | 3,661 | 18,953 | 30,776 | 36,959 | 44,334 | 79,312 | 58,132 | 12,708 | 14,488 | 17,083 | 19,153 | 21,568 | 24,107 | 20,065 | 8,376 | 6,518 |
Retained Earnings | -0.3% | -637,767 | -635,574 | -633,876 | -630,342 | -626,849 | -624,187 | -607,718 | -595,532 | -586,088 | -577,973 | -540,724 | -523,590 | -188,900 | -514,827 | -183,439 | -181,879 | -177,700 | -172,430 | -167,500 | -163,811 | -157,044 |
Additional Paid-In Capital | 0.0% | 642,374 | 642,302 | 637,050 | 637,172 | 634,697 | 627,935 | 626,739 | 626,380 | 623,118 | 622,399 | 620,125 | 581,823 | 199,019 | 529,435 | 189,353 | 189,049 | 188,755 | 188,271 | 187,574 | 172,162 | 163,538 |
Shares Outstanding | 0.0% | 23,457 | 23,457 | 3,453 | 3,452 | 2,649 | 519 | 451 | 386 | 371 | 357 | 172 | 91.00 | 79.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 5,074 | - | - | - | 10,658 | - | - | - | 37,324 | - | - | - | 4,300 | - | - | - | 16,600 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 15.7% | -2,072 | -2,457 | -2,780 | -6,662 | -5,061 | -2,829 | -5,273 | -6,422 | -7,378 | -3,426 | -7,800 | -2,188 | -1,961 | -1,762 | -976 | -998 | -4,814 | -4,879 | -3,989 | -4,356 | -9,642 |
Share Based Compensation | -34.5% | 72.00 | 110 | 216 | 218 | 222 | 240 | -1.50 | 1,489 | 719 | 2,256 | 10,234 | -364 | 101 | 298 | 259 | 292 | 470 | 683 | 659 | 536 | 1,105 |
Cashflow From Investing | - | - | - | - | -3.00 | -7.00 | -79.00 | -33.00 | 18.00 | 2.00 | -3,067 | -89.00 | 5,130 | -119 | -2,160 | -148 | 244 | -326 | -150 | -24.00 | -1.00 | 2,531 |
Cashflow From Financing | -100.0% | - | 5,461 | -338 | 2,250 | 10,201 | 638 | 3.00 | - | - | - | -3,033 | 35,332 | 1,000 | 5,069 | 1,500 | 4,506 | - | -296 | 9,880 | -6,814 | 10,608 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Condensed Consolidated Statements of Operations | ||
Revenue | $ 1,944 | $ 2,287 |
Cost of revenue | 779 | 1,063 |
Gross profit | 1,165 | 1,224 |
Operating expenses: | ||
Sales and marketing | 1,019 | 2,182 |
General and administrative | 1,872 | 4,220 |
Research and development | 484 | 453 |
Total operating expenses | 3,375 | 6,855 |
Operating loss | (2,210) | (5,631) |
Other expense (income), net: | ||
Interest (income) expense, net | (9) | 5 |
Gain on changes in fair value of liability warrants | (21) | (2,965) |
(Gain) loss on foreign currency exchange, net | 24 | (21) |
Other | (25) | (2) |
Loss before income tax provision | (2,179) | (2,648) |
Income tax expense | 14 | 14 |
Net loss | $ (2,193) | $ (2,662) |
Net loss per share - basic and diluted: | ||
Net loss per share - basic (in dollars per share) | $ (0.09) | $ (1.56) |
Net loss per share - diluted (in dollars per share) | $ (0.09) | $ (1.56) |
Shares used to compute basic net loss per share (in shares) | 23,457,127 | 1,708,141 |
Shares used to compute diluted net loss per share (in shares) | 23,457,127 | 1,708,141 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,379 | $ 4,459 |
Restricted cash | 100 | 100 |
Accounts and other receivables (net of allowance for doubtful accounts of $458 and $804, respectively) | 1,566 | 1,659 |
Inventory | 3,467 | 3,741 |
Prepaid expenses and other current assets | 383 | 337 |
Total current assets | 7,895 | 10,296 |
Property and equipment, net | 54 | 60 |
Operating lease right-of-use assets | 226 | 250 |
Deferred tax asset, net | 27 | 28 |
Other assets | 29 | 29 |
Total assets | 8,231 | 10,663 |
Current liabilities: | ||
Accounts payable | 1,314 | 1,689 |
Accrued and other liabilities | 1,930 | 1,814 |
Warranty liability, current | 163 | 163 |
Operating lease liabilities, current | 112 | 111 |
Total current liabilities | 3,519 | 3,777 |
Operating lease liabilities, noncurrent | 127 | 151 |
Common stock warrant liability | 51 | 72 |
Total liabilities | 3,697 | 4,000 |
Commitments and contingencies (Note 10) | ||
Stockholders' equity: | ||
Common stock, $0.001 par value; 300,000,000 shares authorized at March 31, 2024 and December 31, 2023; 23,457,090 and 23,457,047 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 23 | 23 |
Additional paid-in capital | 642,374 | 642,302 |
Accumulated deficit | (637,767) | (635,574) |
Accumulated other comprehensive loss | (96) | (88) |
Total stockholders' equity | 4,534 | 6,663 |
Total liabilities and stockholders' equity | 8,231 | 10,663 |
Series C convertible preferred stock | ||
Stockholders' equity: | ||
Preferred stock, 10,000,000 shares authorized: Series C convertible preferred stock, $0.001 par value; 95,388 shares issued and outstanding at March 31, 2024 and December 31, 2023 |